[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100549032":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":29,"locations":38,"responsibleParty":62,"collaborators":10,"id":64,"slug":10,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":77,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":86,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Xuanwu Hospital, Beijing","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"hydrocephalus",null,"high throughput sequencing and electromyography Whole Genome Sequencing, Whole Exome Sequencing, Transcriptomics, Proteomics, Metabolomics and imaging, such as DTIALPS",[13],"Diagnostic Test: hydrocephalus group",{"label":15,"type":10,"description":16,"interventionNames":17},"Normal group","Whole Genome Sequencing, Whole Exome Sequencing, Transcriptomics, Proteomics, Metabolomics",[18],"Other: normal group",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","hydrocephalus group","Diagnostic Test: high throughput sequencing and electromyography Whole Genome Sequencing, Whole Exome Sequencing, Transcriptomics, Proteomics, Metabolomics and imaging, such as DTIALPS",[9],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"normal group","Whole Genome Sequencing, Whole Exome Sequencing, Transcriptomics, Proteomics, Metabolomics and imaging, such as DTIALPS",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"fengzeng jian, md","CONTACT","01083198899","jianfengzeng@xwh.ccmu.edu.cn",{"name":36,"role":32,"phone":33,"phoneExt":10,"email":37},"xin qu, md","xinqu@xwhosp.org",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Fengzeng Jian","RECRUITING","Beijing","Beijing Municipality","100053","China","CN",{"type":48,"coordinates":49},"Point",[50,51],116.39723,39.9075,{"lat":51,"lon":50},[54,57,59],{"name":55,"role":32,"phone":10,"phoneExt":10,"email":56},"Yuan Chenghua","yuanchenghua@ccmu.edu.cn",{"name":58,"role":32,"phone":10,"phoneExt":10,"email":34},"Jian Fengzeng",{"name":60,"role":61,"phone":10,"phoneExt":10,"email":10},"xin qu, dr","SUB_INVESTIGATOR",{"type":63,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100549032",false,"NCT06428734","Clinical Outcome in Patients With INPH","Phenotypes, Biomarkers and Pathophysiology in INPH","Inclusion Criteria:\n\n* patients who was diagnosed as idiopathic normal pressure hydrocephalus\n\nExclusion Criteria:\n\n* patient received surgical treatment or interventional treatment before patient is pregnant patient unable to complete follow-up patient with other types of hydrocephalus other nervous system diseases",true,"ALL","18 Years","80 Years",{"count":75,"type":76},200,"ESTIMATED","2 Years","OBSERVATIONAL","The aim of this study is to determine the clinical spectrum and natural progression of idiopathic normal pressure hydrocephalus （iNPH ) and related disorders in a prospective single center study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the etiology and molecular mechanisms of these diseases.",[81,82,83,84,85],"Hydrocephalus","Idiopathic Normal Pressure Hydrocephalus","CSF","Glympathic System","Omic",[81,82],"2024-05-20",{"date":89,"type":90},"2024-05-24","ACTUAL",{"date":92,"type":76},"2024-05-15",{"date":94,"type":76},"2027-05",{"name":5,"class":6},1]